4//SEC Filing
Kleiner Perkins Caufield & Byers XIV, LLC 4
Accession 0000899243-18-017718
CIK 0001693664other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 5:13 PM ET
Size
14.2 KB
Accession
0000899243-18-017718
Insider Transaction Report
Form 4
Transactions
- Disposition from Tender
Common Stock
2018-06-22$50.00/sh−4,266,683$213,334,150→ 0 total(indirect: By KPCB Holdings, Inc., as nominee)
KPCB XVI Founders Fund, LLC
10% Owner
Transactions
- Disposition from Tender
Common Stock
2018-06-22$50.00/sh−4,266,683$213,334,150→ 0 total(indirect: By KPCB Holdings, Inc., as nominee)
Transactions
- Disposition from Tender
Common Stock
2018-06-22$50.00/sh−4,266,683$213,334,150→ 0 total(indirect: By KPCB Holdings, Inc., as nominee)
KPCB XIV Associates, LLC
10% Owner
Transactions
- Disposition from Tender
Common Stock
2018-06-22$50.00/sh−4,266,683$213,334,150→ 0 total(indirect: By KPCB Holdings, Inc., as nominee)
KPCB XIV Founders Fund, LLC
10% Owner
Transactions
- Disposition from Tender
Common Stock
2018-06-22$50.00/sh−4,266,683$213,334,150→ 0 total(indirect: By KPCB Holdings, Inc., as nominee)
KPCB XVI Associates, LLC
10% Owner
Transactions
- Disposition from Tender
Common Stock
2018-06-22$50.00/sh−4,266,683$213,334,150→ 0 total(indirect: By KPCB Holdings, Inc., as nominee)
Footnotes (3)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated May 9, 2018, by and among the Issuer, Eli Lilly and Company ("Parent") and Bluegill Acquisition Corporation ("Merger Sub"), a wholly-owned subsidiary of Parent, Merger Sub made a cash tender offer (the "Offer") to purchase each outstanding share of the Issuer's common stock for $50.00 per share (the "Offer Price"), net to the seller in cash, without interest and less any applicable tax withholding. These shares were tendered into the Offer and, after the expiration of the Offer at one minute after 11:59 pm Eastern Time on June 21, 2018, Merger Sub accepted all of the tendered shares and the holder was entitled to receive the Offer Price per share.
- [F2]Consists of 3,475,576 shares of common stock held by Kleiner Perkins Caufield & Byers XIV, LLC ("KPCB XIV"), 294,029 shares of common stock by KPCB XIV Founders Fund, LLC ("KPCB XIV FF"), 480,625 shares of common stock held by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 16,453 shares of common stock held by KPCB XVI Founders Fund, LLC ("KPCB XVI FF"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee" for the accounts of such entities. The managing member of KPCB XIV and KPCB XIV FF is KPCB XIV Associates, LLC ("KPCB XIV Associates"). Brook Byers, L. John Doerr, William Gordon and Theodore Schlein, the managing members of KPCB XIV Associates, and Dr. Beth Seidenberg, a member of KPCB XIV Associates, exercise shared voting and dispositive control over the shares held by KPCB XIV and KPCB XIV FF. The managing member of KPCB XVI and KPCB XVI FF is KPCB XVI Associates, LLC ("KPCB XVI Associates").
- [F3](Continued from Footnote 2) L. John Doerr, Eric Feng, Wen Hsieh, Randy Komisar, Dr. Beth Seidenberg and Theodore Schlein, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and KPCB XVI FF.
Documents
Issuer
ARMO BioSciences, Inc.
CIK 0001693664
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001505781
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 5:13 PM ET
- Size
- 14.2 KB